Search for: "Market Health, Inc."
Results 481 - 500
of 5,173
Sort by Relevance
|
Sort by Date
26 Jun 2022, 1:29 am
On Thursday, the FDA denied Juul marketing authorization due to potential health risks. [read post]
24 Jun 2022, 11:23 am
Harte-Hanks Shoppers, Inc., see our prior post here. 2. [read post]
23 Jun 2022, 12:57 pm
One defendant, Daniel Tondre, was a sales representative for Insys Therapeutics, Inc. [read post]
23 Jun 2022, 9:15 am
The US Food and Drug Administration (FDA) Thursday issued marketing denial orders (MDOs) to all JUUL Labs Inc. products currently marketed in the US. [read post]
21 Jun 2022, 8:46 am
DaVita Inc. laid out a roadmap for private insurers to shift the costs of end-stage renal disease to Medicare, as the court approved a private health plan that singles out the provision of outpatient dialysis for low reimbursement, a plan likely to push those patients out of the private market and onto Medicare. [read post]
19 Jun 2022, 1:40 pm
Food and Drug Administration (FDA) issued a public health notification alerting health care providers about complications from pelvic mesh implants used to treat SUI and POP. [read post]
16 Jun 2022, 9:05 pm
Our bipartisan Working Group is comprised of leading academics, former Commission officials, and market participants who have studied and overseen development of SEC rules for decades, including: Fifteen former senior SEC officials, including four SEC Chairs, five SEC Commissioners, five SEC General Counsel, and four Directors of the SEC’s Division of Corporation Finance; Seventeen senior scholars of corporate, securities and administrative law, as well as accounting and finance, from… [read post]
16 Jun 2022, 10:04 am
Hardeman is being closely watched by the financial markets because of its potential effect on Monsanto’s popular herbicide, “Roundup. [read post]
15 Jun 2022, 12:18 pm
Vital Pharmaceuticals, Inc., 2022 WL 1599712, No. [read post]
15 Jun 2022, 12:10 pm
Nutramax Laboratories, Inc., No. [read post]
13 Jun 2022, 6:00 am
Irbesartan is manufactured by Lupin Pharmaceuticals Inc., and has been on the market since 1997. [read post]
12 Jun 2022, 6:39 pm
D’Agostino v. ev3, Inc., 845 F.3d 1 (1st Cir. 2016), was seen as a death knell for the fraud‑on-the-FDA theory in FCA cases. [read post]
12 Jun 2022, 9:41 am
The post Quick Links from the Past Year, Part 3 (Trademarks) appeared first on Technology & Marketing Law Blog. [read post]
10 Jun 2022, 7:47 am
BANKROLL 6735206 GE GANAWAY EDGE THE EDGE THAT LASTS FOREVER 6721882 MUSICPROFESSOR 6733275 GODSEND GARAGE 6727838 V 6733227 BOSMA CENTER FOR VISIONARY SOLUTIONS 6735043 ASSMANN 6741060 LOVE GANGSTER INC. 6726255 ADAP-TABLE 6734929 6726208 COUNCIL 6721521 TFE 6721445 3 FLOYDS BARBARIAN HAZE IPA 6734551 THE PRODUCE MOMS 6726145 REAL SOLUTIONS FOR REAL PEOPLE 6721328 BROWN GIRL BEAUTY 6734509 WORKERB 6734507 TERATECH IO 6726114 PARADOLIA 6721276 6732936 GTF GROW THE FAITH 6732935 GROW THE… [read post]
10 Jun 2022, 6:33 am
Securities and Exchange Commission, on Thursday, June 9, 2022 Tags: Capital markets, Information asymmetries, Investor protection, Retail investors, SEC, Securities regulation [read post]
10 Jun 2022, 6:33 am
Securities and Exchange Commission, on Thursday, June 9, 2022 Tags: Capital markets, Information asymmetries, Investor protection, Retail investors, SEC, Securities regulation [read post]
3 Jun 2022, 8:46 am
Clark’s Market, Inc. presented the Colorado Supreme Court with a prime dispute to decide whether Colorado employers may implement policies that could, under certain conditions, prohibit payment of earned but unused vacation time when an employee is separated from employment. [read post]
2 Jun 2022, 9:02 pm
Paul TolnaiAbout the author: Paul Tolnai is business development manager for Icicle Technologies Inc. [read post]
1 Jun 2022, 5:57 pm
” The complaint alleges that Glock “through their marketing practices in the manufacture, distribution, and sale of guns, including the subject Glock firearm, have contributed to creating and maintaining a public nuisance in the State of New York and have endangered the public health and safety[.] [read post]
1 Jun 2022, 12:35 pm
This recent FDA action formalizes an April 15, 2022 announcement by TG Therapeutics Inc. that it is pulling Ukoniq from the market after a study showed a possible increased risk of death in patients taking the drug. [read post]
